
|
 |
Making Their Mark: Creating Their Legacies
Two EMTM Graduates Collaborate on Finding New Uses for an Emerging Technology
"When you're a researcher, you have a certain sixth sense and you know when you've stumbled onto something
good," says Peter Gabriele EMTM '03. That moment came for Gabriele and John D'Ottavio EMTM '03, colleagues at
Adhesives Research and at the time, recent graduates of the technology management program when they
stumbled on the concept that would become their next business venture. After extensive market analysis,
the duo, along with two colleagues, Jeff Robertson and Mike Flemmens, established a new division in Adhesives
Research called ARmark Authentication Technologies in 2005.
"I saw this new technology, called microtagging, being utilized in agricultural seeds. But I immediately thought
of a pill, and wondered if we could adapt a similar method for the pharmaceutical industry," says Gabriele.
D'Ottavio recalls walking down the hallway one day at Adhesive Research headquarters when Gabriele pulled him
into a conference room. It was Gabriele who, one year into the program himself, had convinced D'Ottavio to apply
to EMTM in the first place. D'Ottavio immediately understood the value of Gabriele's idea. "He showed me what he
was thinking about and I was fascinated," D'Ottavio says.
Microtagging is a nanotechnology that enables writing on surfaces as small as 75 microns less than the
diameter of a human hair. It is particularly useful in anti-counterfeit brand protection, as companies can tag
their products with what are essentially tiny watermarks.
While other anti-counterfeit and tracking devices are already used in pharmaceutical packaging materials, D'Ottavio
and Gabriele recognized that they could apply microtagging technology to imprint covert markers directly on capsules
and tablets themselves. "If you're making a product, like, for instance, Lipitor, it makes more sense to print your
assurance on the pill itself and not just on the packaging," Gabriele says.
Since ARmark Authentication Techologies was established in 2005, it has sold the technology to write customizable
logos in microtext on materials as various as clothing fibers, packaging and currency, in addition to an edible,
FDA-compliant method for tagging food and pharmaceutical products. ARmark's tags, which can be inserted in the
manufacturing process, make it nearly impossible to reverse-engineer or replicate a tagged product. The company
has also developed an optical device to read micro-markings.
Gabriele currently serves as the technical director in the newly formed entity and D'Ottavio serves as regulatory
affairs manager, working to identify and mitigate barriers to the adoption of the technology by the pharmaceutical
industry.
Both D'Ottavio and Gabriele credit EMTM for giving them the ability to think as entrepreneurs, analyze the technologies
from a business perspective and communicate their ideas to executive leadership.
"When you start a new company you have to tell a story and that story has to be credible. EMTM gave us the solid
foundation to back up our proposition. We are now able to support the business with our understanding of emerging
technologies and entrepreneurship," Gabriele says.
D'Ottavio describes the endeavor as being as entrepreneurial as "you can get without starting your own company." "It's
been a great process of building a new company with the funding and support of a mature entity while developing the
technology from the ground up," says D'Ottavio. "We're using a very wide skill set to turn our vision into a commercial
reality."
D'Ottavio says EMTM's marketing curriculum allows him to differentiate ARmark's products in a way that brings value to
customers. "I came into this business with a better understanding of how to maximize the return on the investment both
for our company and for customers adopting the technology. With Peter and me, there's a common methodology and a shared
language from the program."
"One of the best things EMTM gave me was a tremendous amount of self-confidence to be a businessperson after having been
a lab geek most of my life," Gabriele says.
Last September ARmark was mentioned in a Scientific American story about emerging technologies for avoiding food
contamination, and previously the microtagging technology was demonstrated for FDA commissioner Andrew Eschenbach.
"It's going to take some time for full adoption of this technology," D'Ottavio says. "What we're doing is fairly new
but there is nothing else like it out there."
Top of Page
|
 |
 |

“When you start a new company you have to tell a story and that story has to be credible. EMTM gave us the solid
foundation to back up our proposition. We are now able to support the business with our understanding of emerging
technologies and entrepreneurship.”
Peter Gabriele, MS, EMTM '03
Technical Director
ARmark, Inc.
Glen Rock, PA
|

“I came into this business with a better understanding of how to maximize the return on the investment both
for our company and for customers adopting the technology. With Peter and me, there's a common methodology and a shared
language from the program.”
John D'Ottavio, EMTM '03
Regulatory Affairs Manager
ARmark, Inc.
Glen Rock, PA
|
Please refer to "EMTM Profiles" in this issue for more information on
Peter and John.
> Peter Gabriele, MS, EMTM '03
> John D'Ottavio, EMTM '03
|
|